A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy
Clinical trial NCT04159493 · WITHDRAWN
Trial details
- NCT number
- NCT04159493
- Sponsor
- Aspen USA Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-05
- Primary completion
- 2023-02-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.